Community Acquired Pneumonia
61
2
2
34
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.6%
4 terminated out of 61 trials
89.5%
+3.0% vs benchmark
18%
11 trials in Phase 3/4
15%
5 of 34 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 34 completed trials
Clinical Trials (61)
Epidemiological Study on Community Acquired Pneumonia
Derivation and Validation of the Risk Evaluation Score for Pneumonia Involving Resistant Entities (RESPIRE)
HVNI vs CPAP in Children With Acute Respiratory Distress
Comparing Antibiotic Treatment Strategies for Children With Pneumonia in Outpatient Settings: (STAMPP)
Coenzyme Q10 in Pediatric Community-Acquired Pneumonia
Efficacy of Oral Nigella Sativa as Adjuvant Therapy in Children With Moderate Persistent Asthma
Community-Acquired Pneumonia : Evaluation of Corticosteroids
A Validation Study on a Prognostic Prediction Model for Respiratory Tract Infections
The Effect of Focused Lung Ultrasonography on Antibiotic Prescribing in General Practice
Electrical Impedance Imaging Techniques in Guiding the Use of Chest Physiotherapy in Patients with Pneumonia
Retrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hospitalized for CAP and CSSTi Treated With Zinforo in Multiple Countries
HOME FIRST Pilot: a Study of Early Supported Discharge in Patients With Lower Respiratory Tract Infections
Pathogen Detection and Community Acquired Pneumonia
Reduction of Antibiotic Therapy by Biomakers in Patients With CAP Episodes (REDUCE Study)
Lung Ultrasound for Community-acquired Pneumonia Diagnosis in Emergency Medicine
Pharmacokinetics of XueBiJing in Patients With Sepsis
Evaluation the Clinical Value of Xiyanping Injection in the Treatment of Community-acquired Pneumonia in Children
Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia
Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumonia
A Molecular Toolkit for the Microbial Investigation of Severe Community Acquired Pneumonia